-
2023-505266-29-00
7
2023-11-14
Advanced or metastatic solid tumors
-
2023-505420-62-00
5
2023-11-09
Multiple sclerosis
-
2022-502426-41-00
5
2023-10-17
Thromboprophylaxis in good and intermediate prognosis advanced germ ce
-
2022-500587-35-01
5
2023-07-06
Stroke
-
2024-513669-38-00
5
2023-05-17
Stroke, Ischemic, TIA, Cardiac Disease, Atherosclerosis, Myocardial In
-
2024-513195-18-00
5
2023-03-27
Severe asthma
-
2023-503481-23-00
5
2023-03-20
Maintenance treatment in metastatic non-squamous lung cancer
-
2024-511866-36-00
5
2023-03-11
patients hospitalized in ICU with ESBL-producing Enterobacteriaceae se
-
2023-508852-21-00
4
2022-06-10
Resectable, Early-stage (II to IIIB) Non-small Cell Lung Cancer
-
2022-502425-18-00
5
2022-04-19
Adenocarcinoma of the prostate
-
2023-507568-38-00
1
2022-01-14
Metastatic or locally advanced tumors
-
2024-515075-36-00
6
2021-12-01
kidney transplantion -Epstein Barr virus
-
2024-514843-27-00
6
2021-10-11
Severe asthma
-
2024-513427-17-00
6
2021-05-20
Well controlled severe allergic asthma
-
2024-515019-22-00
5
2021-02-26
Septic shock
-
2023-506914-32-00
4
2020-05-05
Pan tumor
-
2024-514156-33-00
5
2019-08-20
Patients in remission for granulomatosis with polyangiitis (GPA,
Wegen
-
2024-511862-35-00
4
2019-07-19
Adults with non-contrast-enhancing diffuse brainstem gliomas with non-
-
2023-508072-11-00
5
2019-06-26
Castration-resistant prostate cancer
-
2023-508302-24-00
4
2019-05-07
Locally Advanced/Metastatic Urothelial Cancer
-
2024-514094-22-00
5
2019-01-18
Intrecerebral Haemorrhage
-
2022-501254-10-00
5
2018-08-24
Advanced tumors
-
2024-518578-15-00
5
2018-02-05
Is to demonstrate a non inferior efficacy of azithromycin and so the p
-
2023-506027-29-00
5
2014-10-01
Children, adolescents and adults with newly diagnosed diffuse intrinsi